585 related articles for article (PubMed ID: 19413698)
1. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
Lehman EM; Wilson ML
J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
[TBL] [Abstract][Full Text] [Related]
2. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection.
Sypsa V; Touloumi G; Tassopoulos NC; Ketikoglou I; Vafiadis I; Hatzis G; Tsantoulas D; Akriviadis E; Delladetsima J; Demonakou M; Hatzakis A
J Viral Hepat; 2004 Jul; 11(4):366-74. PubMed ID: 15230860
[TBL] [Abstract][Full Text] [Related]
3. Global burden of disease (GBD) for hepatitis C.
Global Burden Of Hepatitis C Working Group
J Clin Pharmacol; 2004 Jan; 44(1):20-9. PubMed ID: 14681338
[TBL] [Abstract][Full Text] [Related]
4. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections.
Deuffic-Burban S; Mohamed MK; Larouze B; Carrat F; Valleron AJ
J Hepatol; 2006 Mar; 44(3):455-61. PubMed ID: 16310281
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C and hepatitis B-related mortality in Spain.
García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
[TBL] [Abstract][Full Text] [Related]
6. Natural histories of hepatitis C virus infection in men and women simulated by the Markov model.
Tanaka J; Kumada H; Ikeda K; Chayama K; Mizui M; Hino K; Katayama K; Kumagai J; Komiya Y; Miyakawa Y; Yoshizawa H
J Med Virol; 2003 Jul; 70(3):378-86. PubMed ID: 12767000
[TBL] [Abstract][Full Text] [Related]
7. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
8. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.
Mostafa A; Taylor SM; el-Daly M; el-Hoseiny M; Bakr I; Arafa N; Thiers V; Rimlinger F; Abdel-Hamid M; Fontanet A; Mohamed MK
Liver Int; 2010 Apr; 30(4):560-6. PubMed ID: 20141592
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
10. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
[TBL] [Abstract][Full Text] [Related]
11. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.
Armstrong GL; Alter MJ; McQuillan GM; Margolis HS
Hepatology; 2000 Mar; 31(3):777-82. PubMed ID: 10706572
[TBL] [Abstract][Full Text] [Related]
12. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States.
Hu KQ; Tong MJ
Hepatology; 1999 Apr; 29(4):1311-6. PubMed ID: 10094980
[TBL] [Abstract][Full Text] [Related]
13. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.
Cacoub P; Geffray L; Rosenthal E; Perronne C; Veyssier P; Raguin G;
Clin Infect Dis; 2001 Apr; 32(8):1207-14. PubMed ID: 11283811
[TBL] [Abstract][Full Text] [Related]
14. Modelling and calibration of the hepatitis C epidemic in Australia.
Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma and hepatitis C in the United States.
El-Serag HB
Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
[TBL] [Abstract][Full Text] [Related]
16. Projecting future complications of chronic hepatitis C in the United States.
Davis GL; Albright JE; Cook SF; Rosenberg DM
Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
[TBL] [Abstract][Full Text] [Related]
17. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.
Buti M; San Miguel R; Brosa M; Cabasés JM; Medina M; Angel Casado M; Fosbrook L; Esteban R
J Hepatol; 2005 May; 42(5):639-45. PubMed ID: 15826711
[TBL] [Abstract][Full Text] [Related]
18. Understanding hepatitis C.
McHutchison JG
Am J Manag Care; 2004 Mar; 10(2 Suppl):S21-9. PubMed ID: 15084064
[TBL] [Abstract][Full Text] [Related]
19. Modelling the past, current and future HCV burden in France: detailed analysis and perspectives.
Deuffic-Burban S; Mathurin P; Valleron AJ
Stat Methods Med Res; 2009 Jun; 18(3):233-52. PubMed ID: 19036916
[TBL] [Abstract][Full Text] [Related]
20. Modeling the hepatitis C virus epidemic in France.
Deuffic S; Buffat L; Poynard T; Valleron AJ
Hepatology; 1999 May; 29(5):1596-601. PubMed ID: 10216148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
